Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 29:4:69.
doi: 10.3389/fphar.2013.00069. eCollection 2013.

Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial

M J Kooy  1 , B L G van Wijk, E R Heerdink, A de Boer, M L Bouvy
Affiliations

Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial

M J Kooy et al. Front Pharmacol. .

Abstract

Background: Lipid-lowering treatment with statins has proven to be effective in reducing cardiovascular events and mortality. In daily practice, however, adherence to medication is often low and this compromises the therapeutic effect. The aim of this study was to assess the effectiveness of an electronic reminder device (ERD) with or without counseling to improve refill adherence and persistence for statin treatment in non-adherent patients.

Methods: A multicenter, community pharmacy-based, randomized controlled trial was conducted in 24 pharmacies in the Netherlands among patients with pre-baseline refill adherence rates between 50 and 80%. Eligible patients aged 65 years or older were randomly assigned to 1 of 3 groups: (1) counseling with an ERD (n = 134), (2) ERD with a written instruction (n = 131), and a (3) control group that received the usual treatment (n = 134).

Main outcome measure: refill adherence to statin treatment for a 360-day period after inclusion (PDC360). Patients with a refill rate ≥80% were considered adherent. The effect among subgroups was also assessed.

Results: There were no relevant differences at baseline. In the counseling with ERD group 54 of 130 eligible patients received the counseling with ERD. In the ERD group, 117 of 123 eligible patients received the ERD. The proportions of adherent patients in the counseling with ERD-group (69.2%) and in the ERD group (72.4%) were not higher than in the control group (64.8%). Among women using statins for secondary prevention, more patients were adherent in the ERD group (86.1%) than in the control group (52.6%) (p < 0.005). In men using statins for secondary prevention the ERD was found to have no effect.

Conclusion: In this randomized controlled trial, no statistically significant improvement of refill adherence was found if an ERD was used with or without counseling. However, in a subgroup of women using statins for secondary prevention the ERD did improve adherence significantly.

Keywords: electronic reminder device; intervention; medication adherence; pharmacy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trial profile.
Figure 2
Figure 2
ERD, Compliance Card®. This credit-card size ERD needs to be activated after the first dose and gives a signal after every 24-h interval following its activation. It actively needs to be turned off. An instruction for the first use is printed on the card.
Figure 3
Figure 3
Information about inclusion of patients in ERD/counseling group.
See this image and copyright information in PMC

References

    1. Andrade S. E., Kahler K. H., Frech F., Chan K. A. (2006). Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol. Drug Saf. 15, 565–574 discussion: 575–577. 10.1002/pds.1230 - DOI - PubMed
    1. Buurma H., Bouvy M. L., De Smet P. A., Floor-Schreudering A., Leufkens H. G., Egberts A. C. (2008). Prevalence and determinants of pharmacy shopping behaviour. J. Clin. Pharm. Ther. 33, 17–23 10.1111/j.1365-2710.2008.00878.x - DOI - PubMed
    1. Campbell M. J., Julious S. A., Altman D. G. (1995). Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 311, 1145–1148 10.1136/bmj.311.7013.1145 - DOI - PMC - PubMed
    1. Carey I. M., DeWilde S., Shah S. M., Harris T., Whincup P. H., Cook D. G. (2012). Statin use after first myocardial infarction in UK men and women from 1997 to 2006: who started and who continued treatment? Nutr. Metab. Cardiovasc. Dis. 22, 400–408 10.1016/j.numecd.2010.09.010 - DOI - PubMed
    1. Chapman R. H., Benner J. S., Petrilla A. A., Tierce J. C., Collins S. R., Battleman D. S., et al. (2005). Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch. Intern. Med. 165, 1147–1152 10.1001/archinte.165.10.1147 - DOI - PubMed

LinkOut - more resources